Migraine headache is present in the aura phase : A prospective study

Neurology

Volumn 79, Issue 20, 2012, Pages 2044-2049

  Hansen, Jakob M ^a,h   Lipton, Richard B ^b   Dodick, David W ^c   Silberstein, Stephen D ^d   Saper, Joel R ^e   Aurora, Sheena K ^f   Goadsby, Peter J ^g   Charles, Andrew ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

^d THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^e Michigan Head Pain and Neurological Institute   (United States)

^f Swedish Pain Center   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; HEADACHE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MIGRAINE WITH AURA; MULTICENTER STUDY; NAUSEA; PHONOPHOBIA; PHOTOPHOBIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 84871181494     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182749eed     Document Type: Article

References (39)

1. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343-349.
2. Menken M, Munsat TL, Toole JF. The global burden of disease study: implications for neurology. Arch Neurol 2000;57:418-420.
3. Olesen J, Gustavsson A, Svensson M, Wittchen HU, Jonsson B. The economic cost of brain disorders in Europe. Eur J Neurol 2012;19:155-162.
4. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA 2003;290:2443-2454.
5. Lipton RB, Stewart WF, Scher AI. Epidemiology and economic impact of migraine. Curr Med Res Opin 2001;17 (suppl 1):s4-s12.
6. Headache Classification Committee. The International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004; 24(suppl 1):9-160.
7. Blau JN. Migraine: theories of pathogenesis. Lancet 1992; 339:1202-1207.
8. Lipton RB, Dodick DW, Silberstein SD, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallelgroup, sham-controlled trial. Lancet Neurol 2010;9:373-380.
9. Kelman L. Pain characteristics of the acute migraine attack. Headache 2006;46:942953.
10. Olesen J, Bousser MG, Diener HC, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006;26:742-746.
11. Russell MB, Iversen HK, Olesen J. Improved description of the migraine aura by a diagnostic aura diary. Cephalalgia 1994;14:107-117.
12. Cologno D, Torelli P, Manzoni GC. A prospective study of the headache phase in 32 migraine with aura patients. Cephalalgia 2002;22:411-415.
13. Eriksen MK, Thomsen LL, Olesen J. Sensitivity and specificity of the new international diagnostic criteria for migraine with aura. J Neurol Neurosurg Psychiatry 2005; 76:212-217.
14. RussellMB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain 1996;119:355-361.
15. Kelman L. The aura: a tertiary care study of 952 migraine patients. Cephalalgia 2004;24:728-734.
16. Bates D, Ashford E, Dawson R, et al. Subcutaneous sumatriptan during the migraine aura. Sumatriptan Aura Study Group. Neurology 1994;44:1587-1592.
17. Olesen J, Diener HC, Schoenen J, Hettiarachchi J. No effect of eletriptan administration during the aura phase of migraine. Eur J Neurol 2004;11:671-677.
18. Aurora SK, Barrodale PM, McDonald SA, Jakubowski M, Burstein R. Revisiting the efficacy of sumatriptan therapy during the aura phase of migraine. Headache 2009;49: 1001-1004.
19. Artto V, Nissila M, Wessman M, Palotie A, Farkkila M, Kallela M. Treatment of hemiplegic migraine with triptans. Eur J Neurol 2007;14:1053-1056.
20. Klapper J, Mathew N, Nett R. Triptans in the treatment of basilar migraine and migraine with prolonged aura. Headache 2001;41:981984.
21. Goadsby PJ, Zanchin G, Geraud G, et al. Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan. Cephalalgia 2008;28:383-391.
22. Klapper J, Lucas C, Rosjo O, Charlesworth B. Benefits of treating highly disabled migraine patients with zolmitriptan while pain is mild. Cephalalgia 2004;24:918924.
23. Diener HC, Dodick DW, Goadsby PJ, Lipton RB, Almas M, Parsons B. Identification of negative predictors of pain-free response to triptans: analysis of the eletriptan database. Cephalalgia 2008;28:35-40.
24. Slof J. Cost-effectiveness analysis of early versus non-early intervention in acute migraine based on Evidence from the 'Act when mild' study. Appl Health Econ Health Policy 2012;10:201-215.
25. Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 2004;55:19-26.
26. Linde M, Mellberg A, Dahlof C. Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack. Cephalalgia 2006;26:113-121.
27. Maizels M. Intranasal lidocaine to prevent headache following migraine aura. Headache 1999;39:439-442.
28. Kaube H, Herzog J, Kaufer T,DichgansM, Diener HC. Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology 2000;55:139-141.
29. Rozen T. Cessation of hemiplegic migraine auras with greater occipital nerve blockade. Headache 2007;47:917919.
30. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981;9:344-352.
31. Leão AAP. Spreading depression of activity in the cerebral cortex. J Neurophysiol 1944;7:359-390.
32. Zhang X, Levy D, Noseda R, Kainz V, Jakubowski M, Burstein R. Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura. J Neurosci 2010;30:8807-8814.
33. Zhang X, Levy D, Kainz V, Noseda R, Jakubowski M, Burstein R. Activation of central trigeminovascular neurons by cortical spreading depression. Ann Neurol 2011;69:855-865.
34. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002; 8:136-142.
35. Olesen J, Friberg L, Olsen TS, et al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990;28:791-798.
36. Goadsby PJ. Migraine, aura, and cortical spreading depression: why are we still talking about it? Ann Neurol 2001;49:4-6.
37. Giffin NJ, Ruggiero L, Lipton RB, et al. Premonitory symptoms in migraine: an electronic diary study. Neurology 2003;60:935940.
38. Baha M, Nachit-Ouinekh F, El Hasnaoui A. Intrapatient variability of migraine attacks: stability analysis of the MIGSEV scale. Headache 2008;48:79-85.
39. Nachit-Ouinekh F, Chrysostome V, Henry P, Sourgen C, Dartigues JF, El Hasnaoui A. Variability of reported headache symptoms and diagnosis of migraine at 12 months. Cephalalgia 2005;25:117-123.